BIH

Berlin-based research project MSTARS is entering its second round. Matthias Selbach and Fabian Coscia explain how the Max Delbrück Center is contributing, why the collaboration with Charité is so important, and how studying proteins in cells can help identify the best therapy for a patient.

Michael Potente wants to find out what makes blood vessels grow. For his work on the metabolic regulation of such growth, he has been selected as the recipient of the 2023 Judah Folkman Award from the North American Vascular Biology Organization.

MyoPax develops regenerative therapies for previously incurable muscle diseases. An interview with co-founders Prof. Simone Spuler and Dr. Verena Schöwel-Wolf, now board member and CEO respectively

Armaghan Naghipour, State Secretary for Science, Research and Equality, informed herself about the development of the Berlin-Buch Science and Biotech Campus on February 10, 2023.

Six sites are now collaborating with the Deutsches Krebsforschungszentrum (German Cancer Research Center) in the National Center for Tumor Diseases (NCT). In Berlin, a central partner is the Charité – Universitätsmedizin Berlin, in close cooperation with the Berlin Institute of Health at the Charité (BIH) and the Max Delbrück Center.

Combining single-cell data with a self-learning algorithm reveals how structural changes in chromosomes can trigger cancer. This new method could pave the way for personalized cancer treatments, writes a team led by Ashley Sanders in “Nature Biotechnology”.

Leif S. Ludwig, a researcher at the Max Delbrück Center and the Berlin Institute of Health at Charité (BIH), will receive the Paul Ehrlich and Ludwig Darmstaedter Young Investigator Award 2023 for a new method to analyze the formation of blood cells, as the Scientific Council of the Paul Ehrlich Foundation announced today.

Il-Kang Na, BIH Johanna Quandt Professor and head of a research group at the Experimental and Clinical Research Center (ECRC), became the new director of the BIH Charité Clinician Scientist Program on January 1, 2023. Her own journey has made her a role model for aspiring clinician scientists.

Anita Waltho is a PhD in the Lab of Thomas Sommer – and one of the early career researchers in Berlin who run a mini podcast series. It showcases change in the academic research environment. Highly recommended!

They have their sights set on serious diseases: Gabriele G. Schiattarella analyzes mechanisms of heart failure, Simon Haas wants to improve immunotherapies for leukemia and Michael Sigal would like to prevent gastrointestinal diseases. Now, the ERC is awarding the researchers with a Starting Grant.